WEBINAR
Improve ROI with Fast Assessment of Decarboxylation Status in Cannabis and Hemp Extracts
Now Available On-Demand
A key step in cannabis oil production is the decarboxylation of naturally produced THCA to psychotropic THC or CBDA to CBD, respectively. This step can be done either before extraction by heating the flower or after extraction by heating the cannabis oil.
-(3)333.png?width=350&name=Agilent_Logo_Tag_v_RGB-(4)-(3)333.png "Agilent_Logo_Tag_v_RGB-(4)-(3)333"){kind=logo}
Watch On-Demand Today!
Webinar Summary
A key step in cannabis oil production is the decarboxylation of naturally produced THCA to psychotropic THC or CBDA to CBD, respectively. This step can be done either before extraction by heating the flower or after extraction by heating the cannabis oil. In both cases, heat is used to speed up the decarboxylation process. But with this heating step come considerations and problems. Excess heat or time will degrade the cannabinoids to unwanted side products, and it will tie up production capacity and generally incur higher production costs.
To better control this important processing step, we have developed an infrared (IR) monitoring solution that can track decarboxylation progress in near real-time. We have been able to validate the process for decarboxylation of both THCA and CBDA in both flower and oil. We will present our monitoring solution and the Agilent IR platform that enables this work.
To better control this important processing step, we have developed an infrared (IR) monitoring solution that can track decarboxylation progress in near real-time. We have been able to validate the process for decarboxylation of both THCA and CBDA in both flower and oil. We will present our monitoring solution and the Agilent IR platform that enables this work.
In this webinar, we will cover:
- Near-realtime tracking of decarboxylation.
- What is decarboxylation of cannabinoids, and what is the theoretical background?
- How to sample production lots for reaction monitoring.
- The benefits of IR in-process monitoring.
Speaker Information:
Dr. Markus Roggen
Founder & CEO
Complex Biotech Discovery Ventures (CBDV)
Founder & CEO
Complex Biotech Discovery Ventures (CBDV)
